Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04827953
Title Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 Before Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer (NUMANTIA)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nelum Corp

pancreatic adenocarcinoma


Gemcitabine + Nab-paclitaxel + NLM-001 + Zalifrelimab

Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.